Back to Stakeholders
Categories

1 domain / 2 areas / 2 specializations

Pharmaka Clinical Consulting

Data updated

US psychedelic drug-development consultancy providing clinical trial roadmaps, regulatory planning, and operational integration frameworks for emerging neuropsychiatry programs.

Consultancy & Advisory Snapshot

Clinical & Operational Consulting

Geography

National

Coverage

1 country

Psychedelic Focus

Explicit Psychedelic Focus

Engagement

Active

Pipeline Stage Coverage

Clinical DevelopmentRegulatory AffairsCare Delivery Operations

Client Types

Drug DevelopersClinical Providers / Care Organizations

Consultancy Notes

Pharmaka Clinical Consulting is a California consultancy, incorporated in October 2023 and based in the San Francisco Bay Area, serving emerging biotech companies developing psychedelic and psychoplastogen therapies for mental health disorders. Services cover clinical trial and regulatory roadmaps including IND preparation and Phase I to III design, business strategy and market research, and clinical guidance such as therapist training frameworks and patient safety protocols. Founder Kevin Lanzo, PharmD, previously worked in late-stage clinical development at Roche/Genentech and co-founded the Psychedelic Pharmacists Association.

Verification

Verified

Last Verified

Jul 11, 2026

Primary Service Link

Quick Facts

Type
Other
Website
Visit